Stockreport
What is an H-1B visa? Look to Silicon Valley as Trump seeks $100,000 fee [USA TODAY]
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
What is Trump's proposed H-1B visa fee? How might Trump's H-1B fee impact tech companies? What electronic start issue occurred in the 2025 Acura ADX review? The special visa now facing a $100,000 fee by President Donald Trump has long been favored by Silicon Valley to attract tech workers. On Sept. 19, Trump declared that the H-1B nonimmigrant visa program has been “deliberately exploited” to replace American workers with lower paid and less-skilled labor. To address this, Trump said he's introducing a $100,000 application fee for companies applying for a H-1B visa, with discretion from Homeland Security Secretary Kristi Noem to exempt workers. Research shows visa workers complement American workers due to different skillsets. While Commerce Secretary Howard Lutnick has said all of the “big companies are on board,” H-1Bs are vital to the nation's tech industry, and Trump's fee will likely face legal challenges. Here's what to know about the H-1B visa. How do people qualif
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | GILD | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GILD alerts
GILD alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
NEWS
NEWS
- Update: Gilead Sciences to Acquire Repare Therapeutics' Investigational Cancer Treatment; Repare Shares Rise [Yahoo! Finance][Yahoo! Finance]
- Repare Therapeutics Announces Acquisition of Pol? ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration [Yahoo! Finance][Yahoo! Finance]
- Gilead Sciences to Present at Upcoming Investor Conference[Business Wire]
- Biopharma climbs higher as 9 drugmakers ink ‘pandering' drug price deals with Trump [Yahoo! Finance][Yahoo! Finance]
- 3 Biotech Stocks Wall Street Analysts Are Bullish on for 2026 [Yahoo! Finance][Yahoo! Finance]
- More
GILD
SEC Filings
SEC Filings
- 12/16/25 - Form 4
- 12/16/25 - Form 4
- 12/15/25 - Form 144
- GILD's page on the SEC website
- More